Palogic Value Management’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$414K Sell
1,259
-36
-3% -$12.9K 0.17% 125
2025
Q4
$455K Buy
1,295
+180
+16% +$65.6K 0.19% 114
2025
Q3
$412K Hold
1,115
0.17% 121
2025
Q2
$441K Buy
1,115
+48
+4% +$18K 0.18% 114
2025
Q1
$397K Buy
1,067
+52
+5% +$19.8K 0.17% 115
2024
Q4
$365K Buy
1,015
+8
+0.8% +$2.96K 0.14% 125
2024
Q3
$364K Sell
1,007
-24
-2% -$8.28K 0.12% 133
2024
Q2
$351K Buy
1,031
+9
+0.9% +$3.05K 0.15% 120
2024
Q1
$366K Buy
1,022
+7
+0.7% +$2.35K 0.16% 116
2023
Q4
$304K Buy
1,015
+101
+11% +$28.3K 0.13% 122
2023
Q3
$250K Sell
914
-14
-2% -$4.01K 0.12% 132
2023
Q2
$283K Sell
928
-31
-3% -$8.95K 0.13% 126
2023
Q1
$274K Buy
+959
New +$254K 0.13% 134

Other funds holding SYK

Palogic Value Management's SYK Position: Q1 2026 in Review

Palogic Value Management reduced its Stryker (SYK) stake by 2.8% in Q1 2026, selling an estimated $12.9K and leaving 1,259 shares worth $414K. The position accounts for 0.17% of the portfolio, ranked #125.

Palogic Value Management first reported a position in SYK in Q1 2023 and has held it in 13 quarters since. The position peaked at $455K in Q4 2025. 2,293 funds tracked by Wall St. Rank hold SYK as of Q1 2026.

  • Palogic Value Management held 1,259 shares of Stryker worth $414K as of Q1 2026.
  • Palogic Value Management sold 36 Stryker shares in Q1 2026, an estimated $12.9K.
  • Stryker made up 0.17% of Palogic Value Management's portfolio in Q1 2026, its #125 holding.
  • Palogic Value Management first reported a position in Stryker in Q1 2023 and has held it in 13 quarters since.
  • Palogic Value Management's Stryker position peaked at $455K in Q4 2025.
  • 2,293 funds tracked by Wall St. Rank held Stryker as of Q1 2026.

Based on Palogic Value Management's 13F filing for Q1 2026, filed 15 May 2026.